Skip to main content

Biofrontera Inc.

BFRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001858685

No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.

Other share classesBFRIW

Q2 2026 vs. Q1 2026

How the institutions holding Biofrontera Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of BFRI: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders1219+7
Shares2.39M2.76M+369.5K (+15.4%)
Value$1.94M$2.61M+$674.8K (+34.9%)

New holders (9)

Institutions that held Biofrontera Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to BFRI in Q2 2026
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC157,505$148.9K0.00%
Citadel Advisors LLC104,941$99.2K0.00%
Jane Street Group, LLC93,000$87.9K0.00%
HRT Financial LP43,349$40.0K0.00%
Northern Trust Corp31,536$29.8K0.00%
Jones Financial Companies LLLP10,000$9.71K0.00%
Gsa Capital Partners LLP10,022$9.00K0.00%
Tower Research Capital LLC (TRC)332$3140.00%
Caitong International Asset Management Co., Ltd1$10.00%

Sold out (2)

Institutions that held Biofrontera Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of BFRI in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Susquehanna International Group, LLP38,574$31.2K
Citigroup Inc11,837$9.58K